36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Benet 75 mg Tablets

Trial Profile

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Benet 75 mg Tablets

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs Risedronic acid (Primary)
  • Indications Osteoporosis; Vertebral fracture
  • Focus Therapeutic Use
  • Sponsors Takeda
  • Most Recent Events

    • 15 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 16 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top